Genetic Interactions Between BEN1-and Cytochrome P450-Mediated Brassinosteroid Inactivation

被引:1
|
作者
Tayengwa, Reuben [1 ,2 ]
Westenskow, Shelby R. [1 ]
Peng, Hao [3 ]
Hulbert, Anna K. [1 ]
Neff, Michael M. [1 ]
机构
[1] Washington State Univ, Crop & Soil Sci, Pullman, WA 99164 USA
[2] Univ Maryland, Plant Sci Landscape & Architecture, College Pk, MD USA
[3] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA
基金
美国国家科学基金会; 美国食品与农业研究所;
关键词
PUTATIVE ACYLTRANSFERASE; ARABIDOPSIS; PHOTOMORPHOGENESIS; BRASSINOLIDE; HOMEOSTASIS; ACTIVATION; CYP72C1; PROTEIN; P450S; BAS1;
D O I
10.1111/ppl.14141
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Brassinosteroids (BRs) are essential plant growth-promoting hormones involved in many processes throughout plant development, from seed germination to flowering time. Since BRs do not undergo long-distance transport, cell- and tissue-specific regulation of hormone levels involves both biosynthesis and inactivation. To date, ten BR-inactivating enzymes, with at least five distinct biochemical activities, have been experimentally identified in the model plant Arabidopsis thaliana. Epigenetic interactions between T-DNA insertion alleles and genetic linkage have hindered analysis of higher-order null mutants in these genes. A previous study demonstrated that the bas1-2 sob7-1 ben1-1 triple-null mutant could not be characterized due to epigenetic interactions between the exonic T-DNA insertions in bas1-2 and sob7-1, causing the intronic T-DNA insertion of ben1-1 to revert to a partial loss-of-function allele. We used CRISPR-Cas9 genome editing to avoid this problem and generated the bas1-2 sob7-1 ben1-3 triple-null mutant. This triple-null mutant resulted in an additive seedling long-hypocotyl phenotype. We also uncovered a role for BEN1-mediated BR-inactivation in seedling cotyledon petiole elongation that was not observed in the single ben1-2 null mutant but only in the absence of both BAS1 and SOB7. In addition, genetic analysis demonstrated that BEN1 does not contribute to the early-flowering phenotype, which BAS1 and SOB7 redundantly regulate. Our results show that BAS1, BEN1, and SOB7 have overlapping and independent roles based on their differential spatiotemporal tissue expression patterns
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cytochrome P450-mediated drug interactions
    Flockhart, DA
    Oesterheld, JR
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 9 (01) : 43 - +
  • [2] CIRCADIAN CLOCK ASSOCIATED 1 and ATAF2 differentially suppress cytochrome P450-mediated brassinosteroid inactivation
    Peng, Hao
    Neff, Michael M.
    JOURNAL OF EXPERIMENTAL BOTANY, 2020, 71 (03) : 970 - 985
  • [3] Cytochrome P450-mediated cardiovascular drug interactions
    Scheen, Andre J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (09) : 1065 - 1082
  • [4] Updates on Cytochrome P450-Mediated Cardiovascular Drug Interactions
    Cheng, Judy W. M.
    Frishman, William H.
    Aronow, Wilbert S.
    DM DISEASE-A-MONTH, 2010, 56 (03): : 163 - 179
  • [5] Updates on Cytochrome P450-Mediated Cardiovascular Drug Interactions
    Cheng, Judy W. M.
    Frishman, William H.
    Aronow, Wilbert S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (02) : 155 - 163
  • [6] In vitro and in silico Approaches to Study Cytochrome P450-Mediated Interactions
    Tan, Boon Hooi
    Pan, Yan
    Dong, Amelia Nathania
    Ong, Chin Eng
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2017, 20 : 319 - 328
  • [7] The role of dietary supplements in cytochrome P450-mediated drug interactions
    Foti, Robert S.
    Wahlstrom, Jan L.
    BOLETIN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMATICAS, 2008, 7 (02): : 66 - 84
  • [8] Cytochrome P450-mediated metabolic interactions between donepezil and tadalafil in human liver microsomes
    Yu, Jieun
    Ryu, Ji Hyeon
    Ha Chi, Yong
    Paik, Soo Heui
    Kim, Sang Kyum
    TOXICOLOGY IN VITRO, 2024, 100
  • [9] Models for cytochrome P450-mediated metabolism
    Korzekwa, KR
    Ewing, TJ
    Kocher, JP
    Carlson, TJ
    Pharmaceutical Profiling in Drug Discovery for Lead Selection, 2004, 1 : 69 - 80
  • [10] Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions
    Johansson, Susanne
    Rosenbaum, David P.
    Ahlqvist, Marie
    Rollison, Helen
    Knutsson, Mikael
    Stefansson, Bergur
    Elebring, Marie
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (05): : 466 - 475